Ignite Creation Date:
2025-12-24 @ 11:41 PM
Ignite Modification Date:
2026-02-26 @ 3:15 AM
Study NCT ID:
NCT07295951
Status:
RECRUITING
Last Update Posted:
2025-12-22
First Post:
2025-12-09
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
A Study of 14C-Bleximenib (Radiolabeled) in Participants With Acute Leukemia
Sponsor:
Janssen Research & Development, LLC
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2025-11-18
Start Date Type:
ACTUAL
Primary Completion Date:
2026-06-14
Primary Completion Date Type:
ESTIMATED
Completion Date:
2026-07-13
Completion Date Type:
ESTIMATED
First Submit Date:
2025-12-09
First Submit QC Date:
None
Study First Post Date:
2025-12-22
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2025-12-09
Last Update Post Date:
2025-12-22
Last Update Post Date Type:
ESTIMATED